Aziyo Biologics Inc.

NASDAQ: AZYO · Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM

Aziyo Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
24.38M 49.19M 47.39M
Cost of Revenue
13.67M 29.96M 28.37M
Gross Profit
10.71M 19.22M 19.02M
Operating Income
-35.65M -26.54M -23.03M
Interest Income
n/a n/a n/a
Pretax Income
-54.12M -32.86M -24.78M
Net Income
-53.95M -32.9M -24.83M
Selling & General & Admin
31.2M 36.82M 32.79M
Research & Development
3.79M 8.94M 9.27M
Other Expenses
n/a n/a n/a
Operating Expenses
34.99M 45.76M 42.05M
Interest Expense
4.78M 5.28M 5.32M
Selling & Marketing Expenses
12.55M 20.2M 18.82M
Cost & Expenses
48.66M 75.73M 70.42M
Income Tax Expense
7K 34K 55K
Shares Outstanding (Basic)
29.07M 13.83M 10.44M
Shares Outstanding (Diluted)
29.07M 13.83M 10.44M
EPS (Basic)
-1.86 -2.38 -2.38
EPS (Diluted)
-1.86 -2.38 -2.38
EBITDA
-35.65M -22.38M -19.45M
EBIT
n/a -27.58M -19.45M
Depreciation & Amortization
n/a 4.16M 3.58M